nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—CYP2C9—brain cancer	0.757	1	CbGaD
Glipizide—CYP3A4—Temozolomide—brain cancer	0.0499	0.486	CbGbCtD
Glipizide—CYP3A4—Lomustine—brain cancer	0.0424	0.414	CbGbCtD
Glipizide—CYP3A4—Etoposide—brain cancer	0.0103	0.0999	CbGbCtD
Glipizide—Retinal haemorrhage—Procarbazine—brain cancer	0.0049	0.041	CcSEcCtD
Glipizide—PPARG—Teniposide—Etoposide—brain cancer	0.00352	1	CbGdCrCtD
Glipizide—Retinal haemorrhage—Carmustine—brain cancer	0.00307	0.0257	CcSEcCtD
Glipizide—Traumatic liver injury—Temozolomide—brain cancer	0.00259	0.0217	CcSEcCtD
Glipizide—Eruption—Hydroxyurea—brain cancer	0.00201	0.0168	CcSEcCtD
Glipizide—Visual disturbance—Lomustine—brain cancer	0.00193	0.0161	CcSEcCtD
Glipizide—Digestion impaired—Hydroxyurea—brain cancer	0.00185	0.0155	CcSEcCtD
Glipizide—Gliclazide—VEGFA—brain cancer	0.00154	0.232	CrCbGaD
Glipizide—Pancytopenia—Lomustine—brain cancer	0.0015	0.0125	CcSEcCtD
Glipizide—Glimepiride—CYP2C9—brain cancer	0.00147	0.221	CrCbGaD
Glipizide—Digestion impaired—Temozolomide—brain cancer	0.00144	0.0121	CcSEcCtD
Glipizide—Hepatic function abnormal—Procarbazine—brain cancer	0.00133	0.0111	CcSEcCtD
Glipizide—Haemolytic anaemia—Procarbazine—brain cancer	0.00128	0.0108	CcSEcCtD
Glipizide—Visual impairment—Lomustine—brain cancer	0.00122	0.0102	CcSEcCtD
Glipizide—Gliclazide—CYP2C9—brain cancer	0.00119	0.179	CrCbGaD
Glipizide—Diplopia—Procarbazine—brain cancer	0.00116	0.00971	CcSEcCtD
Glipizide—Liver injury—Temozolomide—brain cancer	0.00115	0.00961	CcSEcCtD
Glipizide—PPARG—endothelium—brain cancer	0.00108	0.102	CbGeAlD
Glipizide—Gait disturbance—Carmustine—brain cancer	0.00102	0.00857	CcSEcCtD
Glipizide—PPARG—blood vessel—brain cancer	0.000997	0.0939	CbGeAlD
Glipizide—Gait disturbance—Temozolomide—brain cancer	0.00099	0.00828	CcSEcCtD
Glipizide—Leukopenia—Lomustine—brain cancer	0.000985	0.00824	CcSEcCtD
Glipizide—Pancytopenia—Procarbazine—brain cancer	0.000952	0.00797	CcSEcCtD
Glipizide—Chlorpropamide—CYP2C9—brain cancer	0.000923	0.139	CrCbGaD
Glipizide—Photosensitivity reaction—Procarbazine—brain cancer	0.000915	0.00766	CcSEcCtD
Glipizide—Aplastic anaemia—Temozolomide—brain cancer	0.000907	0.00759	CcSEcCtD
Glipizide—Tolbutamide—CYP2C9—brain cancer	0.000899	0.135	CrCbGaD
Glipizide—Drowsiness—Procarbazine—brain cancer	0.000894	0.00748	CcSEcCtD
Glipizide—Thrombocytopenia—Lomustine—brain cancer	0.000879	0.00736	CcSEcCtD
Glipizide—Pain—Carboplatin—brain cancer	0.000878	0.00735	CcSEcCtD
Glipizide—Abnormal vision—Carmustine—brain cancer	0.000872	0.0073	CcSEcCtD
Glipizide—Jaundice—Procarbazine—brain cancer	0.000871	0.00729	CcSEcCtD
Glipizide—Sweating—Procarbazine—brain cancer	0.000857	0.00717	CcSEcCtD
Glipizide—Anorexia—Lomustine—brain cancer	0.000856	0.00716	CcSEcCtD
Glipizide—Abnormal vision—Temozolomide—brain cancer	0.000842	0.00705	CcSEcCtD
Glipizide—Decreased appetite—Lomustine—brain cancer	0.00078	0.00653	CcSEcCtD
Glipizide—Flushing—Procarbazine—brain cancer	0.000745	0.00623	CcSEcCtD
Glipizide—Thirst—Temozolomide—brain cancer	0.000737	0.00617	CcSEcCtD
Glipizide—Pancytopenia—Hydroxyurea—brain cancer	0.000737	0.00617	CcSEcCtD
Glipizide—Hyponatraemia—Carmustine—brain cancer	0.000728	0.0061	CcSEcCtD
Glipizide—Diplopia—Carmustine—brain cancer	0.000726	0.00607	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.000726	0.00607	CcSEcCtD
Glipizide—Dysuria—Hydroxyurea—brain cancer	0.000725	0.00607	CcSEcCtD
Glipizide—Chills—Procarbazine—brain cancer	0.00072	0.00603	CcSEcCtD
Glipizide—Arrhythmia—Procarbazine—brain cancer	0.000717	0.006	CcSEcCtD
Glipizide—ABCC8—brainstem—brain cancer	0.000714	0.0673	CbGeAlD
Glipizide—Diplopia—Temozolomide—brain cancer	0.000701	0.00587	CcSEcCtD
Glipizide—Drowsiness—Hydroxyurea—brain cancer	0.000692	0.00579	CcSEcCtD
Glipizide—Tension—Procarbazine—brain cancer	0.000685	0.00574	CcSEcCtD
Glipizide—Nervousness—Procarbazine—brain cancer	0.000678	0.00568	CcSEcCtD
Glipizide—Tremor—Procarbazine—brain cancer	0.000654	0.00548	CcSEcCtD
Glipizide—Hepatobiliary disease—Hydroxyurea—brain cancer	0.000654	0.00548	CcSEcCtD
Glipizide—ABCC8—telencephalon—brain cancer	0.000633	0.0597	CbGeAlD
Glipizide—Syncope—Procarbazine—brain cancer	0.000626	0.00524	CcSEcCtD
Glipizide—Leukopenia—Procarbazine—brain cancer	0.000625	0.00523	CcSEcCtD
Glipizide—Glyburide—CYP2C9—brain cancer	0.000623	0.0938	CrCbGaD
Glipizide—Loss of consciousness—Procarbazine—brain cancer	0.000614	0.00514	CcSEcCtD
Glipizide—Hypertension—Procarbazine—brain cancer	0.000603	0.00505	CcSEcCtD
Glipizide—Pancytopenia—Carmustine—brain cancer	0.000596	0.00498	CcSEcCtD
Glipizide—Myalgia—Procarbazine—brain cancer	0.000595	0.00498	CcSEcCtD
Glipizide—Arthralgia—Procarbazine—brain cancer	0.000595	0.00498	CcSEcCtD
Glipizide—Anxiety—Procarbazine—brain cancer	0.000593	0.00496	CcSEcCtD
Glipizide—Pancytopenia—Temozolomide—brain cancer	0.000575	0.00482	CcSEcCtD
Glipizide—Confusional state—Procarbazine—brain cancer	0.000575	0.00481	CcSEcCtD
Glipizide—Vomiting—Lomustine—brain cancer	0.000571	0.00478	CcSEcCtD
Glipizide—Oedema—Procarbazine—brain cancer	0.00057	0.00477	CcSEcCtD
Glipizide—Dysuria—Temozolomide—brain cancer	0.000567	0.00474	CcSEcCtD
Glipizide—Shock—Procarbazine—brain cancer	0.000561	0.00469	CcSEcCtD
Glipizide—Thrombocytopenia—Procarbazine—brain cancer	0.000558	0.00467	CcSEcCtD
Glipizide—Chills—Hydroxyurea—brain cancer	0.000557	0.00466	CcSEcCtD
Glipizide—Photosensitivity reaction—Temozolomide—brain cancer	0.000553	0.00463	CcSEcCtD
Glipizide—Hyperhidrosis—Procarbazine—brain cancer	0.000551	0.00461	CcSEcCtD
Glipizide—Anorexia—Procarbazine—brain cancer	0.000543	0.00455	CcSEcCtD
Glipizide—Erythema—Hydroxyurea—brain cancer	0.00054	0.00452	CcSEcCtD
Glipizide—Nausea—Lomustine—brain cancer	0.000533	0.00446	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000519	0.00435	CcSEcCtD
Glipizide—ABCC8—pituitary gland—brain cancer	0.000516	0.0486	CbGeAlD
Glipizide—Insomnia—Procarbazine—brain cancer	0.000516	0.00432	CcSEcCtD
Glipizide—Paraesthesia—Procarbazine—brain cancer	0.000512	0.00428	CcSEcCtD
Glipizide—Hepatobiliary disease—Temozolomide—brain cancer	0.000511	0.00428	CcSEcCtD
Glipizide—Somnolence—Procarbazine—brain cancer	0.000507	0.00424	CcSEcCtD
Glipizide—Ill-defined disorder—Hydroxyurea—brain cancer	0.000501	0.0042	CcSEcCtD
Glipizide—Hypoaesthesia—Carmustine—brain cancer	0.000499	0.00418	CcSEcCtD
Glipizide—ABCC8—medulla oblongata—brain cancer	0.000498	0.0469	CbGeAlD
Glipizide—Decreased appetite—Procarbazine—brain cancer	0.000495	0.00415	CcSEcCtD
Glipizide—Malaise—Hydroxyurea—brain cancer	0.000487	0.00408	CcSEcCtD
Glipizide—Constipation—Procarbazine—brain cancer	0.000487	0.00408	CcSEcCtD
Glipizide—Pain—Procarbazine—brain cancer	0.000487	0.00408	CcSEcCtD
Glipizide—Hepatitis—Temozolomide—brain cancer	0.000485	0.00406	CcSEcCtD
Glipizide—Leukopenia—Hydroxyurea—brain cancer	0.000484	0.00405	CcSEcCtD
Glipizide—Visual impairment—Carmustine—brain cancer	0.000484	0.00405	CcSEcCtD
Glipizide—Hypoaesthesia—Temozolomide—brain cancer	0.000483	0.00404	CcSEcCtD
Glipizide—Pharyngitis—Temozolomide—brain cancer	0.000481	0.00403	CcSEcCtD
Glipizide—Feeling abnormal—Procarbazine—brain cancer	0.00047	0.00393	CcSEcCtD
Glipizide—Eye disorder—Carmustine—brain cancer	0.000469	0.00393	CcSEcCtD
Glipizide—Visual impairment—Temozolomide—brain cancer	0.000467	0.00391	CcSEcCtD
Glipizide—Gastrointestinal pain—Procarbazine—brain cancer	0.000466	0.0039	CcSEcCtD
Glipizide—Flushing—Carmustine—brain cancer	0.000466	0.0039	CcSEcCtD
Glipizide—Pancytopenia—Etoposide—brain cancer	0.000461	0.00385	CcSEcCtD
Glipizide—ABCC8—midbrain—brain cancer	0.000455	0.0429	CbGeAlD
Glipizide—Discomfort—Hydroxyurea—brain cancer	0.000455	0.00381	CcSEcCtD
Glipizide—Eye disorder—Temozolomide—brain cancer	0.000453	0.00379	CcSEcCtD
Glipizide—Urticaria—Procarbazine—brain cancer	0.000453	0.00379	CcSEcCtD
Glipizide—Abdominal pain—Procarbazine—brain cancer	0.000451	0.00377	CcSEcCtD
Glipizide—Flushing—Temozolomide—brain cancer	0.00045	0.00377	CcSEcCtD
Glipizide—Arrhythmia—Carmustine—brain cancer	0.000448	0.00375	CcSEcCtD
Glipizide—ABCC8—spinal cord—brain cancer	0.000444	0.0418	CbGeAlD
Glipizide—Oedema—Hydroxyurea—brain cancer	0.000441	0.00369	CcSEcCtD
Glipizide—Erythema—Carmustine—brain cancer	0.000437	0.00366	CcSEcCtD
Glipizide—Chills—Temozolomide—brain cancer	0.000435	0.00364	CcSEcCtD
Glipizide—KCNJ11—endocrine gland—brain cancer	0.000434	0.0409	CbGeAlD
Glipizide—Thrombocytopenia—Hydroxyurea—brain cancer	0.000432	0.00362	CcSEcCtD
Glipizide—KCNJ11—head—brain cancer	0.000428	0.0404	CbGeAlD
Glipizide—Erythema—Temozolomide—brain cancer	0.000422	0.00353	CcSEcCtD
Glipizide—Jaundice—Etoposide—brain cancer	0.000421	0.00353	CcSEcCtD
Glipizide—Anorexia—Hydroxyurea—brain cancer	0.00042	0.00352	CcSEcCtD
Glipizide—Hypersensitivity—Procarbazine—brain cancer	0.00042	0.00351	CcSEcCtD
Glipizide—Vision blurred—Carmustine—brain cancer	0.000412	0.00345	CcSEcCtD
Glipizide—Tremor—Carmustine—brain cancer	0.000409	0.00343	CcSEcCtD
Glipizide—Asthenia—Procarbazine—brain cancer	0.000409	0.00342	CcSEcCtD
Glipizide—Hepatobiliary disease—Etoposide—brain cancer	0.000409	0.00342	CcSEcCtD
Glipizide—Agranulocytosis—Etoposide—brain cancer	0.000403	0.00338	CcSEcCtD
Glipizide—Pruritus—Procarbazine—brain cancer	0.000403	0.00338	CcSEcCtD
Glipizide—ABCC8—endocrine gland—brain cancer	0.0004	0.0377	CbGeAlD
Glipizide—Vision blurred—Temozolomide—brain cancer	0.000398	0.00333	CcSEcCtD
Glipizide—Tremor—Temozolomide—brain cancer	0.000396	0.00331	CcSEcCtD
Glipizide—ABCC8—head—brain cancer	0.000394	0.0372	CbGeAlD
Glipizide—Dyspnoea—Hydroxyurea—brain cancer	0.000393	0.00329	CcSEcCtD
Glipizide—Somnolence—Hydroxyurea—brain cancer	0.000392	0.00328	CcSEcCtD
Glipizide—Ill-defined disorder—Temozolomide—brain cancer	0.000392	0.00328	CcSEcCtD
Glipizide—Leukopenia—Carmustine—brain cancer	0.000391	0.00327	CcSEcCtD
Glipizide—KCNJ11—central nervous system—brain cancer	0.000391	0.0368	CbGeAlD
Glipizide—Diarrhoea—Procarbazine—brain cancer	0.00039	0.00326	CcSEcCtD
Glipizide—Dyspepsia—Hydroxyurea—brain cancer	0.000388	0.00325	CcSEcCtD
Glipizide—Hypoaesthesia—Etoposide—brain cancer	0.000386	0.00323	CcSEcCtD
Glipizide—Decreased appetite—Hydroxyurea—brain cancer	0.000383	0.00321	CcSEcCtD
Glipizide—KCNJ11—cerebellum—brain cancer	0.000382	0.036	CbGeAlD
Glipizide—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000381	0.00319	CcSEcCtD
Glipizide—Malaise—Temozolomide—brain cancer	0.000381	0.00319	CcSEcCtD
Glipizide—Vertigo—Temozolomide—brain cancer	0.000379	0.00318	CcSEcCtD
Glipizide—Leukopenia—Temozolomide—brain cancer	0.000378	0.00316	CcSEcCtD
Glipizide—Hypertension—Carmustine—brain cancer	0.000377	0.00316	CcSEcCtD
Glipizide—Constipation—Hydroxyurea—brain cancer	0.000377	0.00316	CcSEcCtD
Glipizide—Pain—Hydroxyurea—brain cancer	0.000377	0.00316	CcSEcCtD
Glipizide—Dizziness—Procarbazine—brain cancer	0.000377	0.00315	CcSEcCtD
Glipizide—Myalgia—Carmustine—brain cancer	0.000372	0.00311	CcSEcCtD
Glipizide—Anxiety—Carmustine—brain cancer	0.000371	0.0031	CcSEcCtD
Glipizide—Hypertension—Temozolomide—brain cancer	0.000365	0.00305	CcSEcCtD
Glipizide—Feeling abnormal—Hydroxyurea—brain cancer	0.000364	0.00304	CcSEcCtD
Glipizide—Eye disorder—Etoposide—brain cancer	0.000363	0.00304	CcSEcCtD
Glipizide—Vomiting—Procarbazine—brain cancer	0.000362	0.00303	CcSEcCtD
Glipizide—Flushing—Etoposide—brain cancer	0.00036	0.00302	CcSEcCtD
Glipizide—ABCC8—central nervous system—brain cancer	0.00036	0.0339	CbGeAlD
Glipizide—Confusional state—Carmustine—brain cancer	0.00036	0.00301	CcSEcCtD
Glipizide—Arthralgia—Temozolomide—brain cancer	0.000359	0.00301	CcSEcCtD
Glipizide—Myalgia—Temozolomide—brain cancer	0.000359	0.00301	CcSEcCtD
Glipizide—Rash—Procarbazine—brain cancer	0.000359	0.00301	CcSEcCtD
Glipizide—Dermatitis—Procarbazine—brain cancer	0.000359	0.00301	CcSEcCtD
Glipizide—Anxiety—Temozolomide—brain cancer	0.000358	0.003	CcSEcCtD
Glipizide—Headache—Procarbazine—brain cancer	0.000357	0.00299	CcSEcCtD
Glipizide—Oedema—Carmustine—brain cancer	0.000357	0.00298	CcSEcCtD
Glipizide—Discomfort—Temozolomide—brain cancer	0.000355	0.00297	CcSEcCtD
Glipizide—ABCC8—cerebellum—brain cancer	0.000352	0.0332	CbGeAlD
Glipizide—Thrombocytopenia—Carmustine—brain cancer	0.000349	0.00292	CcSEcCtD
Glipizide—Chills—Etoposide—brain cancer	0.000348	0.00292	CcSEcCtD
Glipizide—Confusional state—Temozolomide—brain cancer	0.000347	0.00291	CcSEcCtD
Glipizide—Oedema—Temozolomide—brain cancer	0.000345	0.00288	CcSEcCtD
Glipizide—Anorexia—Carmustine—brain cancer	0.00034	0.00285	CcSEcCtD
Glipizide—Nausea—Procarbazine—brain cancer	0.000339	0.00283	CcSEcCtD
Glipizide—Thrombocytopenia—Temozolomide—brain cancer	0.000337	0.00282	CcSEcCtD
Glipizide—Hyperhidrosis—Temozolomide—brain cancer	0.000333	0.00279	CcSEcCtD
Glipizide—Anorexia—Temozolomide—brain cancer	0.000328	0.00275	CcSEcCtD
Glipizide—Hypersensitivity—Hydroxyurea—brain cancer	0.000325	0.00272	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Carmustine—brain cancer	0.000325	0.00272	CcSEcCtD
Glipizide—Muscle spasms—Etoposide—brain cancer	0.000325	0.00272	CcSEcCtD
Glipizide—Insomnia—Carmustine—brain cancer	0.000323	0.0027	CcSEcCtD
Glipizide—Paraesthesia—Carmustine—brain cancer	0.00032	0.00268	CcSEcCtD
Glipizide—Dyspnoea—Carmustine—brain cancer	0.000318	0.00266	CcSEcCtD
Glipizide—Somnolence—Carmustine—brain cancer	0.000317	0.00265	CcSEcCtD
Glipizide—Asthenia—Hydroxyurea—brain cancer	0.000316	0.00265	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000314	0.00263	CcSEcCtD
Glipizide—Ill-defined disorder—Etoposide—brain cancer	0.000313	0.00262	CcSEcCtD
Glipizide—Insomnia—Temozolomide—brain cancer	0.000312	0.00261	CcSEcCtD
Glipizide—KCNJ11—brain—brain cancer	0.00031	0.0292	CbGeAlD
Glipizide—Decreased appetite—Carmustine—brain cancer	0.00031	0.00259	CcSEcCtD
Glipizide—Paraesthesia—Temozolomide—brain cancer	0.000309	0.00259	CcSEcCtD
Glipizide—Gastrointestinal disorder—Carmustine—brain cancer	0.000308	0.00258	CcSEcCtD
Glipizide—Dyspnoea—Temozolomide—brain cancer	0.000307	0.00257	CcSEcCtD
Glipizide—Somnolence—Temozolomide—brain cancer	0.000306	0.00256	CcSEcCtD
Glipizide—PPARG—endocrine gland—brain cancer	0.000305	0.0287	CbGeAlD
Glipizide—Pain—Carmustine—brain cancer	0.000305	0.00255	CcSEcCtD
Glipizide—Constipation—Carmustine—brain cancer	0.000305	0.00255	CcSEcCtD
Glipizide—Malaise—Etoposide—brain cancer	0.000305	0.00255	CcSEcCtD
Glipizide—Vertigo—Etoposide—brain cancer	0.000304	0.00254	CcSEcCtD
Glipizide—Dyspepsia—Temozolomide—brain cancer	0.000303	0.00254	CcSEcCtD
Glipizide—Leukopenia—Etoposide—brain cancer	0.000302	0.00253	CcSEcCtD
Glipizide—Diarrhoea—Hydroxyurea—brain cancer	0.000302	0.00253	CcSEcCtD
Glipizide—PPARG—head—brain cancer	0.000301	0.0284	CbGeAlD
Glipizide—Decreased appetite—Temozolomide—brain cancer	0.0003	0.00251	CcSEcCtD
Glipizide—Gastrointestinal disorder—Temozolomide—brain cancer	0.000298	0.00249	CcSEcCtD
Glipizide—Loss of consciousness—Etoposide—brain cancer	0.000297	0.00249	CcSEcCtD
Glipizide—Pain—Temozolomide—brain cancer	0.000295	0.00247	CcSEcCtD
Glipizide—Constipation—Temozolomide—brain cancer	0.000295	0.00247	CcSEcCtD
Glipizide—Feeling abnormal—Carmustine—brain cancer	0.000294	0.00246	CcSEcCtD
Glipizide—Hypertension—Etoposide—brain cancer	0.000292	0.00244	CcSEcCtD
Glipizide—Dizziness—Hydroxyurea—brain cancer	0.000292	0.00244	CcSEcCtD
Glipizide—Gastrointestinal pain—Carmustine—brain cancer	0.000292	0.00244	CcSEcCtD
Glipizide—ABCC8—brain—brain cancer	0.000286	0.0269	CbGeAlD
Glipizide—Discomfort—Etoposide—brain cancer	0.000284	0.00238	CcSEcCtD
Glipizide—Feeling abnormal—Temozolomide—brain cancer	0.000284	0.00238	CcSEcCtD
Glipizide—Abdominal pain—Carmustine—brain cancer	0.000282	0.00236	CcSEcCtD
Glipizide—Gastrointestinal pain—Temozolomide—brain cancer	0.000282	0.00236	CcSEcCtD
Glipizide—Vomiting—Hydroxyurea—brain cancer	0.00028	0.00235	CcSEcCtD
Glipizide—Rash—Hydroxyurea—brain cancer	0.000278	0.00233	CcSEcCtD
Glipizide—Confusional state—Etoposide—brain cancer	0.000278	0.00233	CcSEcCtD
Glipizide—Dermatitis—Hydroxyurea—brain cancer	0.000278	0.00233	CcSEcCtD
Glipizide—Headache—Hydroxyurea—brain cancer	0.000276	0.00231	CcSEcCtD
Glipizide—PPARG—central nervous system—brain cancer	0.000275	0.0259	CbGeAlD
Glipizide—Urticaria—Temozolomide—brain cancer	0.000274	0.00229	CcSEcCtD
Glipizide—Abdominal pain—Temozolomide—brain cancer	0.000272	0.00228	CcSEcCtD
Glipizide—Thrombocytopenia—Etoposide—brain cancer	0.00027	0.00226	CcSEcCtD
Glipizide—Hyperhidrosis—Etoposide—brain cancer	0.000267	0.00223	CcSEcCtD
Glipizide—Anorexia—Etoposide—brain cancer	0.000263	0.0022	CcSEcCtD
Glipizide—Hypersensitivity—Carmustine—brain cancer	0.000263	0.0022	CcSEcCtD
Glipizide—Nausea—Hydroxyurea—brain cancer	0.000262	0.00219	CcSEcCtD
Glipizide—Asthenia—Carmustine—brain cancer	0.000256	0.00214	CcSEcCtD
Glipizide—Hypersensitivity—Temozolomide—brain cancer	0.000254	0.00213	CcSEcCtD
Glipizide—Paraesthesia—Etoposide—brain cancer	0.000248	0.00207	CcSEcCtD
Glipizide—Asthenia—Temozolomide—brain cancer	0.000247	0.00207	CcSEcCtD
Glipizide—Dyspnoea—Etoposide—brain cancer	0.000246	0.00206	CcSEcCtD
Glipizide—Somnolence—Etoposide—brain cancer	0.000245	0.00205	CcSEcCtD
Glipizide—Diarrhoea—Carmustine—brain cancer	0.000244	0.00204	CcSEcCtD
Glipizide—Pruritus—Temozolomide—brain cancer	0.000244	0.00204	CcSEcCtD
Glipizide—Decreased appetite—Etoposide—brain cancer	0.00024	0.00201	CcSEcCtD
Glipizide—Gastrointestinal disorder—Etoposide—brain cancer	0.000238	0.00199	CcSEcCtD
Glipizide—Dizziness—Carmustine—brain cancer	0.000236	0.00197	CcSEcCtD
Glipizide—Pain—Etoposide—brain cancer	0.000236	0.00197	CcSEcCtD
Glipizide—Constipation—Etoposide—brain cancer	0.000236	0.00197	CcSEcCtD
Glipizide—Diarrhoea—Temozolomide—brain cancer	0.000236	0.00197	CcSEcCtD
Glipizide—Dizziness—Temozolomide—brain cancer	0.000228	0.00191	CcSEcCtD
Glipizide—Feeling abnormal—Etoposide—brain cancer	0.000227	0.0019	CcSEcCtD
Glipizide—Vomiting—Carmustine—brain cancer	0.000227	0.0019	CcSEcCtD
Glipizide—Gastrointestinal pain—Etoposide—brain cancer	0.000225	0.00189	CcSEcCtD
Glipizide—Rash—Carmustine—brain cancer	0.000225	0.00188	CcSEcCtD
Glipizide—Dermatitis—Carmustine—brain cancer	0.000225	0.00188	CcSEcCtD
Glipizide—Headache—Carmustine—brain cancer	0.000223	0.00187	CcSEcCtD
Glipizide—Vomiting—Temozolomide—brain cancer	0.000219	0.00183	CcSEcCtD
Glipizide—Urticaria—Etoposide—brain cancer	0.000219	0.00183	CcSEcCtD
Glipizide—PPARG—brain—brain cancer	0.000218	0.0206	CbGeAlD
Glipizide—Abdominal pain—Etoposide—brain cancer	0.000218	0.00182	CcSEcCtD
Glipizide—Rash—Temozolomide—brain cancer	0.000217	0.00182	CcSEcCtD
Glipizide—Dermatitis—Temozolomide—brain cancer	0.000217	0.00182	CcSEcCtD
Glipizide—Headache—Temozolomide—brain cancer	0.000216	0.00181	CcSEcCtD
Glipizide—Nausea—Carmustine—brain cancer	0.000212	0.00177	CcSEcCtD
Glipizide—Nausea—Temozolomide—brain cancer	0.000205	0.00171	CcSEcCtD
Glipizide—Hypersensitivity—Etoposide—brain cancer	0.000203	0.0017	CcSEcCtD
Glipizide—Asthenia—Etoposide—brain cancer	0.000198	0.00166	CcSEcCtD
Glipizide—Pruritus—Etoposide—brain cancer	0.000195	0.00163	CcSEcCtD
Glipizide—Diarrhoea—Etoposide—brain cancer	0.000189	0.00158	CcSEcCtD
Glipizide—Dizziness—Etoposide—brain cancer	0.000182	0.00153	CcSEcCtD
Glipizide—CYP2C9—endocrine gland—brain cancer	0.000179	0.0168	CbGeAlD
Glipizide—Vomiting—Etoposide—brain cancer	0.000175	0.00147	CcSEcCtD
Glipizide—Rash—Etoposide—brain cancer	0.000174	0.00146	CcSEcCtD
Glipizide—Dermatitis—Etoposide—brain cancer	0.000174	0.00145	CcSEcCtD
Glipizide—Headache—Etoposide—brain cancer	0.000173	0.00145	CcSEcCtD
Glipizide—Nausea—Etoposide—brain cancer	0.000164	0.00137	CcSEcCtD
Glipizide—CYP3A4—endocrine gland—brain cancer	0.000136	0.0128	CbGeAlD
Glipizide—CYP3A4—central nervous system—brain cancer	0.000123	0.0116	CbGeAlD
